Cancer of Head
Cancer of Head
Explore linked clinical trials. Standard reference: MESH:M03928107 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients | Atrophy, Cancer of Head, Head and Neck Neoplasms, Neoplasms by Site, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, head and neck cancer, malignant tumor of neck, muscular atrophy, neoplasm, nervous system disorder | Recruiting | Not applicable | 2026-09-11 | NCT06722508 | |
| Association Between Tinnitus and Hearing Loss in Locally Advanced Head and Neck Cancer Treated by Radiotherapy Alone or With Chemotherapy: a Prospective and Multicenter Study | Cancer of Head, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Ear Diseases, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neurologic Manifestations, Ototoxicity, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Stomatognathic Diseases, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, hearing disorder, hearing loss disorder, injury, malignant tumor of neck, mouth disorder, neoplasm, nervous system disorder, otorhinolaryngologic disease, radiation injury, salivary gland cancer, salivary gland disorder, squamous cell carcinoma, tinnitus | Recruiting | Not stated | 2026-08-13 | NCT05946577 | |
| RiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer | Cancer of Head, Head and Neck Neoplasms, Neoplasms by Site, head and neck cancer, malignant tumor of neck, neoplasm | Not yet recruiting | Phase 2 | 2026-07-29 | NCT07732634 | |
| A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer | Cancer of Head, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck cancer, head and neck squamous cell carcinoma, malignant tumor of neck, neoplasm, squamous cell carcinoma | Recruiting | Phase 1 | 2026-07-21 | NCT04722523 | |
| Evaluating the Optimal Timing of Acupuncture for Managing Chemoradiation-induced Xerostomia in Patients With Head and Neck Cancers | Cancer of Head, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, Xerostomia, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, malignant tumor of neck, mouth disorder, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, oropharynx squamous cell carcinoma, otorhinolaryngologic disease, salivary gland disorder, squamous cell carcinoma | Not yet recruiting | Not applicable | 2026-06-29 | NCT07674706 | |
| A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer | Cancer of Head, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck cancer, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Phase 2 | 2026-05-12 | NCT05420948 | |
| Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients (OCAPA) | Cancer of Head, Chronic Pain, Head and Neck Neoplasms, Hyperalgesia, Hypesthesia, Neoplasms by Site, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Somatosensory Disorders, malignant tumor of neck, neoplasm, nervous system disorder, neuralgia, neuromuscular disease, peripheral nervous system disorder | Recruiting | Not applicable | 2025-09-02 | NCT04673981 |